Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Definitive Healthcare (DH) Cash from Restructuring (2024 - 2025)

Definitive Healthcare's Cash from Restructuring history spans 2 years, with the latest figure at $243000.0 for Q4 2025.

  • For Q4 2025, Cash from Restructuring rose 26.56% year-over-year to $243000.0; the TTM value through Dec 2025 reached $595000.0, down 51.98%, while the annual FY2025 figure was $595000.0, 51.98% down from the prior year.
  • Cash from Restructuring reached $243000.0 in Q4 2025 per DH's latest filing, up from $160000.0 in the prior quarter.
  • In the past five years, Cash from Restructuring ranged from a high of $1.0 million in Q2 2024 to a low of $160000.0 in Q3 2025.